Fulcrum Therapeutics Inc. (FULC) Misses Q1 EPS by 2c
Tweet
Share
E-mail
Get Alerts FULC Hot Sheet
Join SI Premium – FREE
Fulcrum Therapeutics Inc. (NASDAQ: FULC) reported Q1 EPS of ($0.28), $0.02 worse than the analyst estimate of ($0.26).
For earnings history and earnings-related data on Fulcrum Therapeutics Inc. (FULC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vail Resorts (MTN) 2200 contracts October 145 puts trade into quarter results
- Iran officials pessimistic about deal with U.S. before midterms - Bloomberg
- Corteva and Inari settle lawsuit over seed depository access
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
